Form D · Biotechnology
ADIPO THERAPEUTICS, LLC
Indianapolis, IN · CIK 0001823434
Offering snapshot reported Dec 11, 2024 · SEC filing
- Reported sold
- $4.72M Offering amount: $14.7M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 19, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 11, 2024 | Initial | $4,717,337 | No comparison | 20 | SEC filing |
| Sep 2, 2020 | Initial | $1,250,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-531807
Source: Form D, filed Dec 11, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Clayman | Director |
| Meng Deng | Director |
| Keith Johns | Executive |
| Karen Wurster | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1210 Waterway Blvd.
Indianapolis, IN, 46202
Indianapolis, IN, 46202